Pharmacokinetics of atracurium and laudanosine in intensive care patients with acute respiratory distress syndrome undergoing mechanical ventilation

Clinical Drug Investigation

Volumn 19, Issue 2, 2000, Pages 143-150

  Farenc, Christine ^a   Lefrant, Jean Yves ^b   Audran, Michel ^a   Saissi, Gilbert ^b   De La Coussaye, Jean Emmanuel ^b   Bressolle, Françoise ^a  

^a UNIV MONTPELLIER   (France)

^b NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATRACURIUM; BILIRUBIN; CREATININE; LAUDANOSINE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

EID: 0034090631     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200019020-00007     Document Type: Article

References (28)

1. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Am J Respir Crit Care Med 1994 Mar; 149 (3 Pt 1 ): 818-24
2. Hansen-Flaschen JH, Brazinsky S, Basile C, et al. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA 1991 Nov 27; 266 (20): 2870-5
3. Ward S, Neill EA. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure). Br J Anaesth 1983 Dec; 55 (12): 1169-72
4. Strange C, Vaughan L, Franklin C, et al. Comparison of train- of-four and best clinical assessment during continuous paralysis. Am J Respir Crit Care Med 1997 Nov; 156 (5): 1556-61
5. Watling SM, Dasta JF. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: a review of literature. Crit Care Med 1994 May; 22 (5): 884-93
6. Fahey MR, Rupp SM, Canfell C, et al. Effect of renal failure on laudanosine excretion in man. Br J Anaesth 1985 Nov; 57 (11): 1049-51
7. Lawhead RG, Matsumi M, Peters KR, et al. Plasma laudanosine levels in patients given atracurium during liver transplantation. Anesth Analg 1993 Mar; 76 (3): 569-73
8. Bion JF, Bowden MI, Chow B, et al. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation. Intensive Care Med 1993; 19 Suppl. 2: 94-8
9. Yate PM, Flynn PJ, Arnold RW, et al. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth 1987 Feb; 59 (2): 211-7
10. Ingram MD, Sclabassi RJ, Stiller RL, et al. Cardiovascular and electroencephalographic effects of laudanosine in nephrectomised cats. Br J Anaesth 1986; 58 Suppl. 1: 14-8
11. Chappel DJ, Miller AA, Ward JB, et al. Cardiovascular and neurological effects of laudanosine. Studies in mice and rats and in conscious and anesthetized dogs. Br J Anaesth 1987 Feb; 59 (2): 218-25
12. Hennis PJ, Fahey MR, Canfell PC, et al. Pharmacology of laudanosine in dogs. Anaesthesiology 1986 Jul; 65 (1): 56-60
13. Ward S, Neill EA, Weatherley BC, et al. Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose). Br J Anaesth 1983 Feb; 55 (2): 113-8
14. Kitts JB, Fisher DM, Canfell PC, et al. Pharmacokinetics and pharmacodynamics of atracurium in the elderly. Anaesthesiology 1990 Feb; 72 (2): 272-5
15. Fahey MR, Rupp SM, Fisher DM, et al. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anaesthesiology 1984 Dec; 61 (6): 699-702
16. Ward S, Boheimer N, Weatherley BC, et al. Pharmacokinetcs of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure. Br J Anaesth 1987 Jun; 59 (6): 697-706
17. Parker CJ, Hunter JM. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis. Br J Anaesth 1989 Feb; 62 (2): 177-83
18. Ward S, Weatherley BC. Pharmacokinetics of atracurium and its metabolites. Br J Anaesth 1986; 58 Suppl. 1: 6-10
19. Parker CJ, Jones JE, Hunter JM. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Br J Anaesth 1988 Nov; 61 (5): 531-40
20. Gwinnutt CL, Eddleston JM, Edwards D, et al. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients. Br J Anaesth 1990 Dec; 65 (6): 829-32
21. Grigore AM, Brusco L, Kudora M, et al. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion. Crit Care Med 1998 Jan; 26 (1); 180-3
22. Smith CE, van Miert MM, Parker CJ, et al. A comparison of infusion pharmacokinetics and pharmacodynamics of cisatracurium, the IR-cis IR'-cis isomer of atracurium, with atracurium besylate in healthy patients. Anaesthesia 1997 Sep; 52 (9): 833-41
23. Boyd AH, Eastwood NB, Parker CJ, et al. Comparaison of pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Br J Anaesth 1996 Mar; 76 (3): 382-8
24. Farenc C, Audran M, Lefrant JY, et al. High-performance liquid chromatographic method for determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics. J Chromatogr B 1999 Mar; 724 (1): 117-26
25. Pk-fit computer program, version 1.1.4, 1999, RDPP, Montpellier, France
26. Prielipp RC, Coursin DB, Scuderi PE, et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit. Anesth Analg 1995 Jul; 81 (1): 3-12
27. Sparr HJ, Wierda JM, Proost JH, et al. Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients. Br J Anaesth 1997 Mar; 78 (3): 267-73
28. Peat SJ, Potter DR, Hunter JM. The prolonged use of atracurium in a patient with tetanus. Anaesthesia 1988 Nov; 43 (11): 962-3